Skip to content

Comparison of effect of pelvic floor exercise and sex education on sexual function in postmenopausal women

Comparison of effect of two interventional methods including of kegel excersice and sexual education on sexual function in postmenopausal women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014120320201N1
Enrollment
150
Registered
2015-01-26
Start date
2014-12-14
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Intervention 1: Education on sex issues and how to deal with problems of sexual dysfunction including disorders in desire, arousal, orgasm, and pain
and education using PowerPoint presentation and speech in groups of 10-15 members in a session
and delivery of training booklets and weekly follow-ups for three months. Intervention 2: Intervention 2: Pelvic floor muscles training (Kegel exercises) by PowerPoint presentations and videos in grou
and delivery of training booklets, checklists of daily exercise, and weekly follow-ups for regular exercise for three months. Intervention 3: Control: Education on general issues related to menopause
and delivery of training booklets.
Behavior
Intervention 1: Education on sex issues and how to deal with problems of sexual dysfunction including disorders in desire, arousal, orgasm, and pain
and delivery of training booklets and weekly follow-ups for three months.
Intervention 2: Pelvic floor muscles training (Kegel exercises) by PowerPoint presentations and videos in groups of 10-15 members in a session
and delivery of training booklets, checklists of daily exercise, and weekly follow-ups for regular exercise for three months.
Control: Education on general issues related to menopause such as complaints, nutrition, etc. by PowerPoint presentations and speech in groups of 10-15 members in a session

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Natural menopause (neither surgical nor premature menopause); age 40-60, not having been more than 3 years since the onset of menopause; lack of acute heart diseases; lack of any serious mental illness; absence of severe psychological stress such as an accident or loss of a family member in the past 3 months; having sexual intercourse with husband; the absence of sexual dysfunction in husband; not using herbal medicines containing phytoestrogens or supplements of sexual hormones in any form; not having a drug abuser spouse; having the willingness to participate in interventions to improve sexual function Exclusion criteria: Being unwilling to cooperate in the ongoing investigation; having debilitating diseases (such as cancer) which prevent the person from participating in interventions; having a surgery during the intervention; having marital discord, divorce, death or illness of spouse during the intervention

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Rate of sexual function. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.;Life Quality. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: WHO Quality of Life-BREF (WHOQOL-BREF) questionnaire.;Severity of menopausal symptoms. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Menopause Rating Scale (MRS) questionnaire.;Total Testosterone. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme immunoasay (EIA).;Dehydroepiandrosterone Sulfate (DHEAS). Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme immunoasay (EIA).;SHBG. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzymo-immunometric assay (EIMA).;EStradiol. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme-Linked Fluorescent Immunoassay (FLFA).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Nazarpour

Shahid Beheshti University of Medical Sciences, Midwifery and Nursing Department

soheilanazarpour@sbmu.ac.irsoheilanazrpour@yahoo.comsn_9547@yahoo.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026